4th Quarter 2025
Key topics in this quarter’s edition include:
- Zolgensma Intrathecal (onasemnogene abeparvovec-xioi) for treatment of spinal muscular atrophy
- Sotyktu (deucravacitinib) for treatment of psoriatic arthritis
- Insulin icodec for treatment of type 2 diabetes